Background/Aims: Extracorporeal blood purification systems (EBS) use specific adsorbents for the elimination of toxins and cytokines. The aim of this study was to test different adsorbents for their ability to reduce antibiotics in parallel to extracorporeal blood purification therapy. Methods: The in vitro adsorption experiments were carried out in human plasma with a newly established hydrophobic resin (Amberchrom CG161c) and adsorbents commercially available and approved in the clinics. The concentration of antibiotic was chosen equivalent to the recommended therapeutic dosage applied intravenously and was measured in plasma using ELISA test kits and high-performance liquid chromatography methods. Results: The adsorbent that reduced all tested antibiotics in plasma close to the detection limit was the dia MARS AC250, which is an activated charcoal involved in the Molecular Adsorbents Recirculation System. Conclusion: For better antibiotic monitoring in sepsis treatment, further investigations have to be performed to determine the clearance rate of antibiotics by different EBS devices.

Keywords:
Blood purification, Liver failure, Plasmapheresis, Sepsis, Adsorption, Artificial liver support
1.
Falkenhagen D, Brown GS, Winkler R, Holtz M, Mohrke T, Schneidewind J, Mietzner S, Behm E, Palm M, Loth F, et al: Possibilities of selective and unselective adsorbent development in blood purification. Contrib Nephrol 1990;78:142-154; discussion 154-156.
2.
Peng ZY, Carter MJ, Kellum JA: Effects of hemoadsorption on cytokine removal and short-term survival in septic rats. Crit Care Med 2008;36:1573-1577.
3.
House AA, Ronco C: Extracorporeal blood purification in sepsis and sepsis-related acute kidney injury. Blood Purif 2008;26:30-35.
4.
Ronco C, Brendolan A, Lonnemann G, Bellomo R, Piccinni P, Digito A, Dan M, Irone M, La Greca G, Inguaggiato P, Maggiore U, De Nitti C, Wratten ML, Ricci Z, Tetta C: A pilot study of coupled plasma filtration with adsorption in septic shock. Crit Care Med 2002;30:1250-1255.
5.
Sykora R, Chvojka J, Krouzecky A, Radej J, Kuncova J, Varnerova V, Karvunidis T, Novak I, Matejovic M: Coupled plasma filtration adsorption in experimental peritonitis-induced septic shock. Shock 2009;31:473-480.
6.
Abdul Cader R, Abdul Gafor H, Mohd R, Yen Kong W, Arshad N, Kong N: Coupled plasma filtration and adsorption (CPFA): a single center experience. Nephrourol Mon 2013;5:891-896.
7.
Livigni S, Bertolini G, Rossi C, Ferrari F, Giardino M, Pozzato M, Remuzzi G; GiViTI: Gruppo Italiano per la Valutazione degli Interventi in Terapia Intensiva (Italian Group for the Evaluation of Interventions in Intensive Care Medicine) is an independent collaboration network of Italian Intensive Care units: Efficacy of coupled plasma filtration adsorption (CPFA) in patients with septic shock: a multicenter randomised controlled clinical trial. BMJ Open 2014;4:e003536.
8.
Shimokawa K, Takakuwa R, Wada Y, Yamazaki N, Ishii F: Adsorption of various antimicrobial agents to endotoxin removal polymyxin-B immobilized fiber (toraymyxin®). Part 2: adsorption of two drugs to toraymyxin PMX-20R cartridges. Colloids Surf B Biointerfaces 2013;101:350-352.
9.
Shimokawa K, Takakuwa R, Taya K, Wada Y, Yamazaki N, Murata M, Hirata K, Masuno T, Yokota H, Ishii F: Adsorption of various antimicrobial agents to endotoxin removal polymyxin-B immobilized fiber (toraymyxin®). Colloids Surf B Biointerfaces 2012;90:58-61.
10.
Sartori M, Day S, De Rosa S, Ricatti MG, Nalesso F, Zancato M, Ronco C: Pharmacokinetic analysis of antibiotic adsorption (vancomycin and teicoplanin) by the lixelle extracorporeal unit. Int J Artif Organs 2015;38:8-12.
11.
Dellinger RP, Levy MM, Rhodes A, Annane D, Gerlach H, Opal SM, Sevransky JE, Sprung CL, Douglas IS, Jaeschke R, Osborn TM, Nunnally ME, Townsend SR, Reinhart K, Kleinpell RM, Angus DC, Deutschman CS, Machado FR, Rubenfeld GD, Webb S, Beale RJ, Vincent JL, Moreno R; Surviving Sepsis Campaign Guidelines Committee including the Pediatric Subgroup: Surviving sepsis campaign: international guidelines for management of severe sepsis and septic shock, 2012. Intensive Care Med 2013;39:165-228.
12.
Micek ST, Welch EC, Khan J, Pervez M, Doherty JA, Reichley RM, Kollef MH: Empiric combination antibiotic therapy is associated with improved outcome against sepsis due to gram-negative bacteria: a retrospective analysis. Antimicrob Agents Chemother 2010;54:1742-1748.
13.
Bochud PY, Glauser MP, Calandra T; International Sepsis Forum: Antibiotics in sepsis. Intensive Care Med 2001;27(suppl 1):S33-S48.
14.
Gaieski DF, Mikkelsen ME, Band RA, Pines JM, Massone R, Furia FF, Shofer FS, Goyal M: Impact of time to antibiotics on survival in patients with severe sepsis or septic shock in whom early goal-directed therapy was initiated in the emergency department. Crit Care Med 2010;38:1045-1053.
15.
Thalhammer F, Hörl WH: Pharmacokinetics of meropenem in patients with renal failure and patients receiving renal replacement therapy. Clin Pharmacokinet 2000;39:271-279.
16.
Roehr AC, Frey OR, Koeberer A, Fuchs T, Roberts JA, Brinkmann A: Anti-infective drugs during continuous hemodialysis - using the bench to learn what to do at the bedside. Int J Artif Organs 2015;38:17-22.
17.
Janata O: Antibiotika. pm-Verlag, 2014.
18.
Lofmark S, Edlund C, Nord CE: Metronidazole is still the drug of choice for treatment of anaerobic infections. Clin Infect Dis 2010;50(suppl 1):S16-S23.
19.
Sorgel F, Kinzig M: The chemistry, pharmacokinetics and tissue distribution of piperacillin/tazobactam. J Antimicrob Chemother 1993;31(suppl A):39-60.
20.
Bansal RC, Goyal M: Activated Carbon Adsorption, ed 1. CRC Press, 2005.
21.
Harm S, Falkenhagen D, Hartmann J: Pore size - a key property for selective toxin removal in blood purification. Int J Artif Organs 2014;37:668-678.
22.
Vroman L: Effect of absorbed proteins on the wettability of hydrophilic and hydrophobic solids. Nature 1962;196:476-477.
23.
Vilaseca P, Dawson KA, Franzese G: Understanding and modulating the competitive surface-adsorption of proteins through coarse-grained molecular dynamics simulations. Soft Matter 2013;9:8.
24.
Kramer L, Bauer E, Schenk P, Steininger R, Vigl M, Mallek R: Successful treatment of refractory cerebral oedema in ecstasy/cocaine-induced fulminant hepatic failure using a new high-efficacy liver detoxification device (FPSA-prometheus). Wien Klin Wochenschr 2003;115:599-603.
25.
Lynn RI, Honig CL, Jatlow PI, Kliger AS: Resin hemoperfusion for treatment of ethchlorvynol overdose. Ann Intern Med 1979;91:549-553.
© 2015 S. Karger AG, Basel
2015
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.